Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.78
Delayed Data
As of Jul 25
 +0.01 / +1.30%
Today’s Change
0.26
Today|||52-Week Range
1.51
+75.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues11.5M15.2M4.4M9.2M
 
 
 
 
 
Cost of Goods Sold1.9M5.9M730.0K6.4M
 
 
 
 
 
Depreciation And Amortization3.5M3.1M2.4M2.0M
 
 
 
 
 
 
Operating ExpensesGross Income6.1M6.1M1.3M801.0K
 
 
 
 
 
General Expenses40.7M38.4M29.8M39.8M
 
 
 
 
 
Research And Development33.3M29.8M24.9M30.4M
 
 
 
 
 
Total Operating Expenses46.1M47.5M32.9M48.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.6M-32.3M-28.5M-39.0M
 
 
 
 
 
Extraordinary Credit0.00--0.0014.1M
 
 
Extraordinary Charge-1.0M-1.0M0.000.00
 
 
 
Interest Expense On Debt674.0K4.9M3.7M10.7M
 
 
 
 
 
Other Expenses8.5M8.1M4.9M5.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.8M-29.9M-27.3M-29.2M
 
 
 
 
 
Discontinued Operations0.000.0045.4M-189.0K
 
 
 
Extraordinary Items0.000.0039.9M0.00
 
 
Net Income-27.8M-29.9M18.1M-29.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS92.4M92.9M94.9M101.4M
 
 
 
 
 
Shares To Calculate EPS Diluted92.4M92.9M94.9M101.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.32$0.61-$0.29
 
 
 
 
 
EPS Diluted-$0.30-$0.32$0.19-$0.29